Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy (Q38494601)
Jump to navigation
Jump to search
scientific article published on May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy |
scientific article published on May 2011 |
Statements
1 reference
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy (English)
1 reference
Kim Henriksen
1 reference
Inger Byrjalsen
1 reference
Per Qvist
1 reference
Henning Beck-Nielsen
1 reference
Gitte Hansen
1 reference
Bente J Riis
1 reference
Hans Perrild
1 reference
Ole Lander Svendsen
1 reference
Jeppe Gram
1 reference
Morten A Karsdal
1 reference
Claus Christiansen
1 reference
BALLET Trial Investigators
1 reference
1 May 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference